ArticleBlood cancer journal2023

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases.

Rimal Ilyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.